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Background: Excessive daytime sleepiness (EDS) is central in Attention deficit
hyperactivity disorder (ADHD) but its causes remain unclear. The aim of this study was
to explore objective EDS and homeostatic sleep pressure buildup, evaluated by power
theta–alpha frequency (PTAF), in drug-free sleepy adults with ADHD and controls.
Methods: Participants were placed during a 36-h period of extended wakefulness
under constant routine protocol to strictly control sleep time, sleep duration, and
circadian zeitgebers.
Results: Eight drug-free sleepy patients with ADHD and 7 matched controls were
included. The ADHD group had significantly shorter sleep latency on the Maintenance of
Wakefulness Test (MWT) throughout extended wakefulness than the control group. There
was no significant difference between the groups in PTAF evolution during extended
wakefulness and in kinetic sleep pressure buildup, evaluated by the time constant of
saturating exponential function.
Limitations: The sample was small, so the findings cannot be generalized. Moreover,
psychiatric comorbidities and circadian regulation should be taken into account in
future studies.
Conclusion: In very controlled conditions, mean sleep latency on the MWT during
the whole extended wakefulness was significantly shorter in sleepy patients with ADHD
than in control subjects. However, the difficulty to remain awake during soporific
circumstances observed in these patients with ADHD cannot be explained by changes
in the kinetic of sleep pressure buildup.
Clinical Trials Registration: www.clinicaltrials.gov/, Identifier: NCT02217371.
Keywords: ADHD (attention deficit and hyperactivity disorder), sleepiness, sleep pressure, maintenance of
wakefulness test, phenotype
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INTRODUCTION
Attention deficit hyperactivity disorder (ADHD) is the most
common developmental disorder and is characterized by
inappropriate levels of inattention, impulsivity, and hyperactivity
(1). Follow-up studies have documented the persistence of
ADHD into adulthood in 50–65 % of cases (2). In the USA,
the prevalence of ADHD in adults has been estimated at 4.4
% (3). ADHD significantly affects major life domains, notably
social and occupational functioning. Excessive daytime sleepiness
(EDS) is an interesting focus within the context of ADHD in
adults as shown in studies using an automatic resting EEG
classification of sleepiness (VIGALL, 7 EEG-vigilance stages)
who demonstrated unstable arousal regulation in children and
adults with ADHD. This arousal instability was characterized
by a faster decline to the low EEG-vigilance stages and more
fluctuations in their stages of vigilance (4, 5). Moreover, in a study
(6) conducted on a population of regularly registered highways
drivers: those with ADHD symptoms expressed greater EDS
than those who did not have these. This result was confirmed
by Ito et al. (7), who showed in a web-based study that the
prevalence and severity of EDS in Japanese adults with possible
ADHD were higher than in individuals classified as non-ADHD.
ADHD is highly associated with primary sleep disorders (8),
which could explain the EDS. However, Bioulac et al. (9) found
that a significant proportion of adults with ADHD free of primary
sleep disorders exhibit objective EDS. Therefore, the cause of
objective EDS in ADHD in adults remains elusive and is probably
not unique.
Consistent evidence for circadian rhythm disruption in
ADHD is now emerging. As described by Coogan and
McGowan in their recent systematic review (10), ADHD
is associated with evening chronotype and with delayed
sleep onset with an objectively measured prevalence of
73–78% in both children and adults with ADHD (11,
12). Delayed sleep onset, or delayed sleep phase syndrome
(DSPS), induces a misalignment between circadian time
and social time known as social jetlag (13). The social
jetlag observed mostly in evening chronotype is associated
with sleep restriction, resulting in accumulated EDS over
time (13, 14).
Moreover, DSPS may involve changes in the circadian clock
drive (Process-C) and/or the sleep homeostatic process (Process-
S) (15). Circadian disturbances include an increase in the
circadian period, a shorter phase angle, and the dampening of
rhythms clock gene expression.
Concerning process-S, we previously demonstrated that
evening chronotype feels sleepier during the daytime and that
the kinetics of homeostatic sleep pressure build-up differ between
morning and evening chronotypes (16). Our hypothesis is that
changes in homeostatic sleep pressure build-up could explain
EDS in the sleepy adults ADHD subgroup.
To go further than the aforementioned studies, the aim
of this study was to explore EDS objectified by MWT and
homeostatic sleep pressure in a sleepy ADHD subgroup, and in




Patients with ADHD were recruited from the sleep clinic at the
University Hospital in Bordeaux (France) according to the DSM-
IVR criteria (17). The clinical diagnosis of ADHD was validated
by standardized instruments. Childhood ADHD and the chronic
course of ADHD symptoms from childhood to adulthood were
established by a board-certified psychiatrist who carried out a
clinical evaluation and administered a semi-structured diagnostic
interview (Conners’ Adult ADHDDiagnostic Interview forDSM-
IV, CAADID) (18). The Conners’ Adult ADHD Rating Scales
(CAARS), observer form, was used. Patients with ADHD were
included if they presented a mean sleep latency < 20min on the
Maintenance of Wakefulness Test (MWT) (four MWT trials at
2-h intervals, 10 am, 12 am, 2 pm, 4 pm) (9). According to the
American Academy of Sleep Medicine (AASM), the MWT may
be used to assess an individual’s ability to remain awake when his
or her inability to remain awake constitutes a public or personal
safety issue (19).
We excluded all patients with any clinically relevant medical
or psychiatric condition including current affective or psychotic
disorders, substance abuse within 1 year prior to screening,
and long-term treatment with benzodiazepine. Comorbid
psychiatric disorders were assessed with the Mini International
Neuropsychiatric Interview (MINI 5.0.0., DSM IV).
All patients were withdrawn from psychostimulant
medication for a minimum of 72 h before starting the study.
Healthy control subjects were recruited from the general
population and were matched with ADHD patients according to
age (±5 years), sex and chronotype, as defined by the score on
the Morning Evening Questionnaire (MEQ) (20). We excluded
subjects with any psychiatric disorders or any complaint of sleep
disorder [reported on the Basic Nordic Sleep Questionnaire
(BNSQ)] (21), or an Epworth Sleepiness scale score > 10 (22).
ADHD symptoms were ruled out in the control population with
the Wender Utah Rating Scale for ADHD (23), ASRS (Adult
ADHDSelf-Report Scale) (18 items) (24). Controls were included
if they presented a mean sleep latency > 36min on the MWT
(four MWT trials at 2-h intervals).
For patients and controls, the presence of nocturnal
sleep-disordered breathing (AHI > 10/h) and periodic limb
movements (index > 15/h) were ruled out with ambulatory
polygraphy. Patients and controls with restless leg syndrome and
DSPS were also excluded. Subjects provided written informed
consent, and the local ethics committee [consultative committee
for the protection of persons participating in biomedical research
(CPP Sud-Ouest et Outre-Mer III)] approved the study. The
study is registered at Clinicaltrials.gov (NCT02217371).
Study Design
For 4 days prior to the study, participants were asked to
maintain regular bedtimes and wake-up times according to their
usual preferences. During this period, compliance was checked
by sleep diaries and actimetry. They performed a nocturnal
polysomnography (PSG) just before the constant routine to
control sleep time and duration. The next morning, 1 h after
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their preferential wake-up time, all volunteers underwent a 36-h
period of extended wakefulness in the constant routine protocol
(25). As sleep pressure is generated by the interplay of circadian,
homeostatic drives and preferential social timing (16, 26), the
night before the constant routine, subjects slept according to
their individual and preferential sleep schedule (bedtime and
wake time) in order to not modify the kinetic of sleep pressure.
Volunteers were kept in a constant semi-recumbent posture in
bed and were restricted to very low activity levels, under dim
light (<50 lux) and received hourly snacks throughout the day
and night.
Sleep pressure was evaluated by theta-alpha (6–9Hz) band of
frontal EEG (27) during the Karolinska Drowsiness Test (4-min
eyes-open session, KDT). Frontal power theta–alpha frequency
(fPTAF) was calculated (Hanning window) by 4-s epochs after an
automatic artifact rejection (ACUTE software, Physip France).
Kinetics of sleep pressure buildup were defined by asymptote
and time constant assessed by saturating exponential function
(27). The first MWT trial began about 1H20 after the subject
preferential wake-up time. MWT trials were performed every 4 h
(after 1H20 (T1), 5H20 (T2), 9H20 (T3), 13H20 (T4), 17H20
(T5), 21H20 (T6), 25H20 (T7), 29H20 (T8), and 33H20 (T9) of
wakefulness). Subjects followed classical MWT instructions (28).
Trials were ended after 40min if no sleep occurred or after three
consecutive epochs of stage 1 sleep or after one epoch of any other
stage of sleep. Sleep latency was defined as the first epoch of any
stage of sleep.
During PSG, KDT and MWT, EEG, EOG, and EMG were
recorded on a Brainbox EEG-1042 Amplifier with coherence
software (Natus, France). All electrophysiological signals were
digitized at a sampling rate of 256Hz. KDT and MWT were
repeated every 4 h.
STATISTICAL ANALYSIS
Actimetry and PSG measures were compared between ADHD
patients and controls using Wilcoxon rank tests. Repeated
outcomes (MWT and Process S fPTAF) as well as the constant
and the asymptote of the fPTAF were compared between
groups using linear mixed effects models adjusted for age,
gender, and Hörne and Ostberg score, and taking into account
an interaction between group and time. The analyses were
conducted on available data, using SAS software v9.4 (SAS




Eight ADHD patients and 9 control participants were recruited.
Two control participants withdrew from the experiment during
the constant routine protocol. The sample thus consisted of
15 subjects: 8 ADHD patients (mean age = 39.8 ± 11 years,
range 21–53 years, BMI = 24.6 ± 4.7, 2 males) and 7 control
participants (mean age = 42.6 ± 9.1, range 25–53, BMI = 24.0
± 3.8, 1 male). The meanMEQ score in ADHD patients was 56.8
± 12.7, demonstrating that sleepy ADHD patients were mostly
TABLE 1 | Demographic and clinical characteristics (Mean ± SD) of sleepy ADHD





Demographic and clinical characteristics
Age (years) 39.8 ± 11.0 42.6 ± 9.1
Gender (% females) 75% 85.7%
BMI (kg/m2) 24.6 ± 4.7 24.0 ± 3.8
Mean sleep latency on MWT (min) 13.9 ± 4.5 38.9 ± 2.0
Self-reported questionnaires
MEQ score 56.8 ± 12.7 57.9 ± 2.8
ESS score 16.9 ± 2.4 3.4 ± 2.5
WURS score 55.5 ± 9.4 10.6 ± 7.6
ADHD, attention deficit/hyperactivity disorder; BMI, body mass index; MWT, maintenance
of wakefulness test; MEQ, morningness–eveningness questionnaire; ESS, Epworth
Sleepiness scale; WURS, Wender Utah Rating Scale.
intermediate chronotypes. Only one sleepy ADHD patient was
classified as evening chronotype.
Among the 8 patients with ADHD included, 50% presented
a psychiatric comorbidity (25% had comorbid anxiety disorder
(past or present) and 50% had a history of mood disorders but no
current mood disorder). Fifty percent presented with ADHD of
the mixed subtype and 50% with the inattentive subtype. Patients
with ADHD presented the following scores on the CAARS (58.4
± 15.7) and the Brown questionnaire (69.8± 26.3).
Table 1 shows the demographic and clinical characteristics of
ADHD patients and controls.
Actimetry
There was no significant difference between patients with ADHD
and controls in total sleep time for the four nights before the
protocol (Night 1: 422.6 ± 176.0min vs. 428.0 ± 36.2min, p
=0.41; Night 2: 453.3± 128.2min vs. 437.0± 52.2min, p= 0.73;
Night 3: 419.8 ± 63.9min vs. 385.3 ± 73.6min, p = 0.39; Night
4: 429.3±110.5 vs. 415.7± 40.2, p= 0.73).
Polysomnography
There was no significant difference between patients with ADHD
and controls in total sleep time on PSG the night before the
protocol: 404.8 (50.0) min vs. 392.9 (62.0) p= 0.69.
MWT
The ADHD group had a shorter sleep latency on the MWT than
the control group at T1 [34.4 ± 8.7min vs. 40.0 ± 0.0min (p
= 0.013)]. This significantly shorter sleep latency on the MWT
persists over time, but remains stable over the eight measures (p
= 0.94) (Figure 1).
Process S
There was no significant difference in fPTAF between the groups,
whether at T1 (126.5 ± 173.2 vs. 95.9 ± 101.4 (p = 0.80),
for ADHD patients and controls, respectively) or regarding the
evolution of the eight other measures (p= 0.37) (Figure 2).
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FIGURE 1 | Time course of sleep latency on MWT (Mean ± SE) in sleepy ADHD group and control group during 36-h of sustained wakefulness from T1 to T9.
FIGURE 2 | Time course of fPTAF in sleepy ADHD group and control group during 36-h of sustained wakefulness from T1 to T9 (A) and sleep pressure buildup in
sleepy ADHD and controls assessed by saturating exponential function (B).
Regarding kinetics of sleep pressure buildup, there was no
significant difference between the groups in mean time constant
(33,043.4 ± 68,519.6 h for ADHD patients and 126,303.9 ±
187,901.4 h for controls; p = 0.12), nor in mean asymptote
(112,874.9 ± 206,194.4 for TDAH and 534,873.4 ± 10,004,871.6
for controls; p= 0.18).
DISCUSSION
This study is the first to explore the impact of sustained
wakefulness on objective EDS in drug-free sleepy adults with
ADHD during a 36-h period under constant routine. In
highly controlled conditions (sleep time, sleep duration and
circadian zeitgebers), mean sleep latency on MWT remained
significantly shorter in sleepy patients with ADHD than in
control participants. Indeed, at the beginning of the protocol
(firstMWT), sleepy patients with ADHDdisplayed a significantly
shorter mean sleep latency on theMWT than control participants
and this difference persists throughout the whole constant
routine remaining stable. Contrary to our original hypothesis,
difficulty to remain awake during soporific circumstances cannot
also be explained by a change in homeostatic sleep pressure since
the kinetics of sleep pressure build-up did not differ between
ADHD patients and control subjects.
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This kind of protocol permits to test fundamental hypothesis
about the origin of sleepiness in this subgroup of patients with
ADHD. EDS is sometimes caused by insufficient sleep, a delay
in the sleep phase (29) or by misalignment between circadian
time and social time (social jetlag) (13). As all participants
were matched in chronotype and were asked to follow regular
and preferred sleep-wake schedules and habitual sleep duration
(compliance verified by actimetry) during the 4 days before the
constant routine, the EDS observed in our sleepy patients with
ADHD cannot have been artificially induced by sleep restriction
or social jetlag. Importantly, total sleep time did not differ
between the two groups before the constant routine on actimetry
and PSG.
These findings suggest that EDS in ADHD may have a
central origin, leading to a state of hypo-arousal state, as in
narcolepsy. Miano et al. identified five specific sleep phenotypes
in ADHD children (30) including one called “narcolepsy-like
phenotype” that could correspond to our sleepy ADHD subjects.
This hypothesis is supported by the recent work of Diaz-Roman
et al. (31), who found shorter REM latency and higher levels of
EDS in children with ADHD than in control children. These data
might indicate early signs or shared symptoms of narcolepsy in
these children with ADHD. In support of a continuum between
ADHD and central hypersomnia, Lopez et al. (32) found a
high frequency of ADHD and ADHD-like symptoms in patients
with central hypersomnia, explaining high levels of EDS and
hypersomnolence in adults with ADHD. In a new model of
sleep/wake regulation, Fulcher et al. (33) extended the model of
Phillips and Robinson (34) by demonstrating that the dynamics
of sleep and wake may be controlled not only by circadian
rhythms and homeostatic drive but also by orexin levels. The
model posits that a reduction in orexin levels leads to reduced
daytime arousal without altering any other drives, as observed in
our sleepy ADHD subgroup.
Moreover, we cannot exclude the effect of circadian changes
associated with ADHD especially the phase delay of circadian
phase (11, 35) on EDS even if the patients with ADHD included
in this study were classified mostly in intermediate chronotype.
Although it is still not certain whether circadian amplitude is
impaired in ADHD patients, further studies will have to fully
explore changes in circadian phase, circadian period, circadian
entrainment, and/or polymorphisms in genes controlling the
circadian drive.
This study has several limitations. First, the sample was small
given the heaviness of the protocol, so the findings cannot be
generalized. Consequently, we could not take DSM-IV subtypes
into account. Second, our patients had psychiatric comorbidities,
half of them suffering from another psychiatric disorder, as
expected. A limit of our study is that we did not control
for stressful life events which typically can be associated with
reduced sleep causing daytime sleepiness. Therefore, the EDS
in our patients with ADHD may have been influenced by
psychiatric comorbidities. Moreover, we cannot exclude the effect
of circadian changes associated with ADHD especially the phase
delay of circadian phase on EDS even if the patients with ADHD
included in this study were classified mostly in intermediate
chronotype. Although it is still not certain whether circadian
amplitude is impaired in ADHD patients (10), further studies
will have to fully explore changes in circadian phase, circadian
period, circadian entrainment, and/or polymorphisms in genes
controlling the circadian drive. Finally, we cannot totally exclude
an after effect over 72 h due to withdrawal-related hypersomnia
symptoms (36). However, in the literature, most of ADHD-
related studies commonly stopped psychostimulants treatment
for a period of 48–72 h before the protocol (37, 38). Further
studies will have to control this limiting factor.
In conclusion, this study conducted in highly controlled
conditions revealed a significant and stable difference in mean
sleep latency on the MWT between drug-free sleepy patients
with ADHD and control subjects. The difference cannot be
explained by specific changes in the kinetics of sleep pressure
buildup with ADHD. EDS is a key objective biomarker to
better evaluate ADHD patients. The clinical implications are
that personalized pharmacologic treatment with wakefulness-
promoting drugs could improve cognition and behaviors in
sleepy ADHD patients.
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